Oncology - Lung

ASCO Guideline: Management of dyspnea in advanced cancer

24 Feb, 2021 | 02:10h | UTC

Management of Dyspnea in Advanced Cancer: ASCO Guideline – Journal of Clinical Oncology

 

Commentary on Twitter (thread – click for more)

1/ How can we better manage dyspnea in people with advanced cancer?

Wonderful to see this new @ASCO Guideline out.

Led by Drs. @DrDavidHui and @campbell_meg #supponc #pallonc

Full text: https://t.co/qbdhzbibKw pic.twitter.com/f2Qf6GswvK

— Arjun Gupta (@guptaarjun90) February 23, 2021

 

---

Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline Update

19 Feb, 2021 | 02:04h | UTC

Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline Update – Journal of Clinical Oncology

 

---

RCT: Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%

18 Feb, 2021 | 02:34h | UTC

Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial – The Lancet

 

Commentary on Twitter

Phase 3 trial suggests #cemiplimab could be used as new first-line monotherapy option for patients with advanced non-small-cell #lungcancer with PD-L1 of at least 50%—it improved overall & progression-free survival compared with chemotherapy. Read https://t.co/O06Of6wx07 pic.twitter.com/KtQ24lEoR5

— The Lancet (@TheLancet) February 17, 2021

 

---

Radiation therapy for small-cell lung cancer: ASCO Guideline endorsement of an ASTRO Guideline

29 Jan, 2021 | 01:27h | UTC

Radiation Therapy for Small-Cell Lung Cancer: ASCO Guideline Endorsement of an ASTRO Guideline – Journal of Clinical Oncology

 

---